Prostate cancer management is rapidly evolving with the introduction of advanced, minimally invasive technologies. One such innovation is Robotic High-Intensity Focused Ultrasound (HIFU), which is gaining global attention for its precision and organ-preserving approach.
At USICON 2026, Indian urologists will have the opportunity to gain direct insights into this technology through a dedicated scientific session led by a globally renowned expert.
Scientific Session at USICON 2026
A special 45-minute scientific session titled “Robotic HIFU in Prostate Cancer Treatment: The Focal One® Experience” will be conducted during USICON 2026. The session will focus on the clinical application of Robotic HIFU in the treatment of localized prostate cancer.
This session is designed to provide practical, experience-based knowledge rather than theoretical discussion, making it highly relevant for practicing urologists.
Session Details
-
- Event: USICON 2026
-
- Topic: Robotic HIFU in Prostate Cancer Treatment – The Focal One® Experience
-
- Date: 29 January 2026
-
- Time: 1:30 PM – 2:00 PM
-
- Duration: 30 Minutes
-
- Venue: USICON 2026 (Hall to be announced)
-
- Format: Semi-live demonstration with a pre-recorded clinical case
About the Speaker – Prof. Pascal Rischmann
The session will be delivered by Prof. Pascal Rischmann, a globally respected name in urology and prostate cancer treatment.
Prof. Rischmann is Professor Emeritus at the University of Toulouse, France, and the former Head of the Department of Urology, Renal Transplantation, and Andrology at Rangueil University Hospital, Toulouse.
With decades of clinical and academic experience, his work has significantly contributed to the development of minimally invasive and image-guided treatments in urology.
Prof. Rischmann’s Clinical and Academic Contributions
-
- International authority in urologic oncology and prostate diseases
-
- Pioneer in the clinical use of High-Intensity Focused Ultrasound (HIFU) for localized prostate cancer
-
- Extensive experience in image-guided and focal therapies
-
- Author and co-author of more than 400 peer-reviewed scientific publications
-
- Former President of the French Urology Association
-
- Former President of the French Academy of Surgery
-
- Active member of the European Association of Urology (EAU)
-
- International member of the American Urological Association (AUA)
His vast experience makes this session highly valuable for Indian urologists looking to understand advanced prostate cancer treatment options.
What the Session Will Cover
During this 45-minute scientific session, Prof. Rischmann will share his real-world clinical experience with Robotic HIFU, focusing on:
-
- The role of HIFU in localized prostate cancer treatment
-
- Patient selection for focal therapy
-
- Treatment planning and precision targeting
-
- Clinical outcomes and safety profile
-
- Functional preservation and quality-of-life considerations
-
- The future of Robotic HIFU in prostate cancer care
A semi-live, pre-recorded clinical case will be used to demonstrate how Robotic HIFU is applied in actual clinical practice.
Understanding Robotic HIFU and Focal One®
Robotic HIFU is a non-invasive treatment technique that uses focused ultrasound energy to precisely ablate cancerous tissue within the prostate while sparing surrounding healthy structures.
Focal One® is an advanced robotic platform that integrates:
-
- High-Intensity Focused Ultrasound (HIFU)
-
- Real-time ultrasound imaging
-
- MRI–ultrasound fusion technology
-
- Robotic precision and navigation
This combination allows accurate targeting of prostate cancer lesions with minimal impact on urinary and sexual function.
Why This Session Is Important for Indian Urologists
This scientific session offers Indian urologists a unique opportunity to:
-
- Learn directly from a global expert with extensive HIFU experience
-
- Understand how Robotic HIFU fits into modern prostate cancer treatment pathways
-
- Explore minimally invasive and organ-preserving treatment options
-
- Gain exposure to international clinical practices and outcomes
As prostate cancer incidence continues to rise, understanding newer technologies like Robotic HIFU becomes increasingly important for evidence-based patient care.
Who Should Read and Attend
This article and session are particularly relevant for:
-
- Urologists
-
- Onco-urologists
-
- Prostate cancer specialists
-
- Surgeons interested in minimally invasive therapies
-
- Healthcare professionals involved in prostate cancer management
Conclusion
The Robotic HIFU >in Prostate Cancer Treatment: The Focal One® Experience session at USICON 2026 represents an important educational opportunity for the Indian urology community.
With Prof. Pascal Rischmann sharing his extensive clinical experience, this session will provide meaningful insights into the evolving role of Robotic HIFU in prostate cancer care and its potential impact on future treatment strategies in India.Prostate Cancer Awareness Series